|
Standard Diagnostics, Inc. is a global leader in the research, development and commercialization of innovative In-vitro diagnostic products for Point of Care Testing of human diseases.
Since New influenza A H1N1 emerged all over the world, almost ninety five thousands cases of New Influenza A H1N1 infection has been reported. To stop further transmission, all countries have tried to screen case of Influenza infection. SD BIOLINE Influenza Ag kits have been distributed to the countries having Influenza surveillance system as a screening tool. Furthermore, SD BIOLINE Influenza Ag kit was recently verified to detect novel Influenza A H1N1 by KCDC (the Korean Center of Disease Control and Prevention).
SD’s flagship product is the ICA rapid test kits for the point of care testing (POCT) of infectious disease, tumor and cardiac markers, hormones and forensics. They are available through 200 distributors in 105 countries world widely. In addition, they have been evaluated by the World Health Organization (WHO), UNICEF, USAID and the Pasteur Institute with great performance.
|
